GE Healthcare Life Sciences Targets High Growth

To counter a 'lull' in US and Western Europe sales, GE Healthcare Life Sciences is targeting significantly increased demand in India for its tools that aid drug discovery. Over the coming year, the company is expecting 30% growth and hopes to capture a greater share of the US$400mn Indian bio-supplies sector. Given the advanced product range assembled by GE Healthcare Life Sciences and a planned increase in headcount, BMI believes that the company is well placed to achieve its

To read the full article, please choose one of the following options: